Evidence map›Paper›PMID 31558726›Full record

ArticleNature communications2019

Author Correction: BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.

Xiaofeng Wang, Su Wang, Emma C Troisi, Thomas P Howard, Jeffrey R Haswell, Bennett K Wolf, William H Hawk, Pilar Ramos, Elaine M Oberlick, Evgeni P Tzvetkov and 5 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. BRD9 functions as an HIV-1 latency regulatory factor.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Xiaofeng WangDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Hanover, NH, 03756, USA.
Su WangDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-9463-6530
Emma C TroisiDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Thomas P HowardDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.ORCID http://orcid.org/0000-0002-3438-2831
Jeffrey R HaswellDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Bennett K WolfDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Hanover, NH, 03756, USA.
William H HawkDepartment of Molecular and Systems Biology, Geisel School of Medicine, Dartmouth College, Hanover, NH, 03756, USA.
Pilar RamosComprehensive Cancer Center and Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Elaine M OberlickDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Evgeni P TzvetkovDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Aaron RossComprehensive Cancer Center and Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Francisca VazquezBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0002-2857-4685
William C HahnBroad Institute of Harvard and MIT, 415 Main Street, Cambridge, MA, 02142, USA.ORCID http://orcid.org/0000-0003-2840-9791
Peter J ParkDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA. peter_park@hms.harvard.edu.ORCID http://orcid.org/0000-0001-9378-960X
Charles W M RobertsDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. Charles.Roberts@STJUDE.ORG.
Dana-Farber Cancer Institute · USBroad Institute · USDartmouth College · USSt. Jude Children's Research Hospital · USHarvard University · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
NIGMS NIH HHS T32 GM007753
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31558726
PMCPMC6763484
OpenAlexW2976787503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.